Venus Remedies Ltd share price logo

Venus Remedies Ltd (VENUSREM)

₹295.850.74%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Venus Remedies Ltd share Performance

  • ₹295
    ₹303.9
    ₹295.85
    downward going graph

    0.29%

    Low

    Day's Volatility:3.01%

    High

    2.72%

    downward going graph
  • ₹195
    ₹430
    ₹295.85
    downward going graph

    34.09%

    Low

    52 Weeks Volatility:79.43%

    High

    45.34%

    downward going graph
1 Month Return-9.86 %
3 Month Return-14.3 %
1 Year Return+ 48.37 %
Previous Close₹298.05
Open₹295.30
Volume24.88K
Upper Circuit-
Lower Circuit-
Market Cap₹398.40Cr

Company Information

Established in 1989, Venus Remedies Limited is a family managed company based out of Panchkula district at Haryana, India. The company specializes in Intravenous/Intramuscular injectible forms and Eye/Ear/Nose drops and has been GMP certified by the WHOGeneva. In 2001, Venus Remedies had tied up with a top Australian company to set-up a Cephalosporin project at a cost of Rs 4.5 crores. The company is also manufacturing injections for leading firms like Panacea Biotech and Morepan Laboratories among others. Over the years, Venus Remedies has been able to successfully introduce 13 new products in their Animal Health division, which include names like Megox3000, Paroxin3000, Pisa3000, MicalRonid and Dexolyte, to name a few.

Share Price: ₹295.85 per share as on 24 May, 2024 04:01 PM
Market Capitalisation: ₹398.40Cr as of today
Revenue: ₹143.42Cr as on December 2023 (Q4 23)
Net Profit: ₹6.85Cr as on December 2023 (Q4 23)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
OrganisationVenus Remedies Ltd
HeadquartersPanchkula
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Venus Remedies Ltd

  • Venus Remedies Expands Reach of Oncology Drugs in Ukraine - 18 Mar, 2024

    Venus Remedies has received marketing authorizations from Ukraine for three cancer drugs, with plans to increase exports by 20% in the next year. The company is also awaiting approval on another 10 applications.

  • Venus Remedies Ltd Stock Price Falls by 26% in a Month - 14 Mar, 2024

    The Venus Remedies Ltd stock price has fallen by 26% over the last month, but it has gained 86% in the past year. The company's P/E ratio of 13.3x is lower than many Indian companies, which could be due to expectations of earnings degradation. Further investigation is required to determine if this is justified.

  • Venus Remedies Secures UNICEF Approval for Antibiotic Supply - 11 Mar, 2024

    Venus Remedies has received good manufacturing practices (GMP) approval from UNICEF to supply Cephalosporin antibiotics for treating infections. The company's Q3 FY24 net profit increased by 108.2% YoY, while net sales grew by 22.7%. The stock shed 0.69% to end at Rs 331.45 on the BSE.

  • Venus Remedies Receives Marketing Authorisation for Oncology Drugs in Ukraine - 08 Mar, 2024

    Venus Remedies has received marketing authorisation for its oncology drugs in Ukraine. The company also received ₹7.5 crore under the Government's Production Linked Incentive scheme for 2022-23. Venus Remedies' stock closed at ₹332.65, up by 1.54% on the NSE.

  • Venus Remedies Receives First Disbursement Under PLI Scheme - 06 Mar, 2024

    Venus Remedies Ltd has received its first disbursement of Rs 7.5 crore under the Indian Government's Production Linked Incentive (PLI) scheme for FY 2022-23, covering 75% of the total incentive due to the company. The disbursement will boost manufacturing capabilities and foster product diversification.

Fundamentals of Venus Remedies Ltd

Insights on Venus Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 56.50% to 56.61% in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 41.76% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 113.6% return, outperforming this stock by 121.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 112.8% return, outperforming this stock by 64.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 9.94 Cr → 6.85 Cr (in ₹), with an average decrease of 31.1% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.59% to 1.48% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, VENUSREM stock has moved down by -23.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 170.77 Cr → 145.77 Cr (in ₹), with an average decrease of 14.6% per quarter

Venus Remedies Ltd Valuation

Venus Remedies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-45.34x)

September 23, 2020

Today (13.62x)

May 24, 2024

Industry (62.95x)

May 24, 2024

Highest (21.70x)

December 28, 2023

LowHigh

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
41.76%
0.00
Foreign Institutions
1.48%
0.00
Mutual Funds
0%
0.00
Retail Investors
56.61%
0.00
Others
0.15%
0.00

Technicals of Venus Remedies Ltd share

News & Events of Venus Remedies Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Venus Remedies Ltd shares.

Venus Remedies Ltd (VENUSREM) share price today is ₹295.85

Venus Remedies Ltd is listed on NSE

Venus Remedies Ltd is listed on BSE

  • Today’s highest price of Venus Remedies Ltd is ₹303.9.
  • Today’s lowest price of Venus Remedies Ltd is ₹295.

PE Ratio of Venus Remedies Ltd is 13.62

PE ratio = Venus Remedies Ltd Market price per share / Venus Remedies Ltd Earnings per share

Today’s traded volume of Venus Remedies Ltd(VENUSREM) is 24.88K.

Today’s market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹398.4Cr.

Venus Remedies Ltd(VENUSREMPrice
52 Week High
₹430
52 Week Low
₹195

Venus Remedies Ltd(VENUSREM) share price is ₹295.85. It is down -31.20% from its 52 Week High price of ₹430

Venus Remedies Ltd(VENUSREM) share price is ₹295.85. It is up 51.72% from its 52 Week Low price of ₹195

Venus Remedies Ltd(VENUSREMReturns
1 Day Returns
-2.2%
1 Month Returns
-9.86%
3 Month Returns
-14.3%
1 Year Returns
48.37%